{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-049937","form_type":"8-K","ticker":"BCAX","cik":"0002023658","company_name":"Bicara Therapeutics Inc.","filed_at":"2026-07-28T12:35:19+00:00","discovered_at":"2026-07-28T12:40:00.345301+00:00","generated_at":"2026-07-28T12:40:09.326097+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bicara Therapeutics appoints Jeremy Bender and Christy Oliger to board; Kiran Mazumdar-Shaw retires","bullets":["Kiran Mazumdar-Shaw resigned from board effective July 28, 2026; no disagreement with company.","Jeremy Bender (former CEO, Day One Biopharmaceuticals) and Christy Oliger (former SVP, Genentech) appointed to board effective July 28, 2026.","Board size increased from nine to ten directors; Bender and Oliger each receive initial option award of 38,950 shares.","New Launch Readiness Committee formed with Kate Haviland as chair, Bender and Oliger as members.","Appointments support Bicara's transition to commercial-stage focus on ficerafusp alfa."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-049937","json":"https://secwatch.observer/filing/0001628280-26-049937.json","markdown":"https://secwatch.observer/filing/0001628280-26-049937.md","text":"https://secwatch.observer/filing/0001628280-26-049937.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026049937/0001628280-26-049937-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023658/000162828026049937/bcax-20260723.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-28T12:40:09.326097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}